Cohen D Joshua, Jacobs Thomas W, Wilson D Scott, Mancini Michael C, Van Duyn Christine, Schwartz Zvi, Boyan Barbara D
Department of Biomedical Engineering, Virginia Commonwealth University, Richmond, Virginia, USA.
Johns Hopkins Medical Institute, Baltimore, Maryland, USA.
Pharmacol Res Perspect. 2025 Jun;13(3):e70119. doi: 10.1002/prp2.70119.
Delivery of bioactive agents to achieve tissue regeneration at targeted sites with minimal side effects requires the use of biodegradable carriers and sustained release of the therapeutic at appropriate concentrations. We developed a copper-free polyethylene glycol-based click hydrogel to deliver bone morphogenetic protein-2 (BMP2), a potent regulator for bone regeneration that is currently delivered to orthotopic sites using an absorbable collagen sponge, leading to a burst release of BMP2, potentially causing ectopic bone formation. In contrast, the hydrogel is delivered as a liquid, conforming to the contours of treatment sites, polymerizing rapidly at body temperature without generating heat, exhibiting minimal swelling after gelation, and releasing its payload as it degrades. We assessed the safety and effectiveness of BMP2 delivery in vitro and in mouse cranial defects in vivo, comparing it to BMP2 delivered via a collagen sponge. No toxicity was observed in vitro or systemically, nor was there allergic sensitization caused by the hydrogel in rabbits. Released BMP2 increased the production of osteogenic markers in vitro. Hydrogel + BMP2 caused equivalent defect closure and total bone growth compared to collagen + BMP2; however, there was more vascularization within the defect but less bone growth outside of the defect on the calvaria for hydrogel + BMP2 compared to collagen + BMP2. In conclusion, the click hydrogels used in this study are safe and effective for administering BMP2 with fewer undesired off-target effects and high potential to be used with BMP2 for bone regeneration, supporting the use of click chemistry hydrogels to deliver bioactive agents to treatment sites safely and effectively.
递送生物活性剂以在目标部位实现组织再生并将副作用降至最低,需要使用可生物降解的载体,并以适当浓度持续释放治疗剂。我们开发了一种无铜的聚乙二醇基点击水凝胶来递送骨形态发生蛋白-2(BMP2),BMP2是一种有效的骨再生调节剂,目前使用可吸收胶原海绵将其递送至原位部位,导致BMP2的爆发式释放,可能会引起异位骨形成。相比之下,水凝胶以液体形式递送,可贴合治疗部位的轮廓,在体温下迅速聚合而不产生热量,凝胶化后肿胀最小,并在降解时释放其负载物。我们在体外和小鼠颅骨缺损体内评估了BMP2递送的安全性和有效性,并将其与通过胶原海绵递送的BMP2进行了比较。在体外或全身均未观察到毒性,水凝胶在兔子中也未引起过敏致敏。释放的BMP2在体外增加了成骨标志物的产生。与胶原+ BMP2相比,水凝胶+ BMP2导致了等效的缺损闭合和总骨生长;然而,与胶原+ BMP2相比,水凝胶+ BMP2在缺损内的血管化更多,但在颅骨缺损外的骨生长较少。总之,本研究中使用的点击水凝胶在施用BMP2时安全有效,具有较少的不良脱靶效应,并且与BMP2一起用于骨再生的潜力很高,支持使用点击化学水凝胶将生物活性剂安全有效地递送至治疗部位。